Net profit of Concord Biotech declined 2.13% to Rs 75.92 crore in the quarter ended December 2024 as against Rs 77.57 crore during the previous quarter ended December 2023. Sales rose 1.42% to Rs 244.22 crore in the quarter ended December 2024 as against Rs 240.80 crore during the previous quarter ended December 2023.
| Particulars | Quarter Ended |
| Dec. 2024 | Dec. 2023 | % Var. |
| Sales | 244.22 | 240.80 | 1 |
| OPM % | 40.11 | 43.99 | - |
| PBDT | 114.42 | 116.64 | -2 |
| PBT | 101.15 | 103.10 | -2 |
| NP | 75.92 | 77.57 | -2 |